KRAMER ROBIN 1609222 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-05 | 2023-06-30 | 2023-06-30 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | dsp | 122.0 | 2.98 | 0.01 | 284.85 | Direct | Common Stock | BIOGEN INC. | code F | 3973.7483 | 144.74 (BIIB) |
| 2023-07-05 | 2023-06-30 | 2023-06-30 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | acq | 252.0 | 6.15 | 0.02 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 4095.7483 | 144.74 (BIIB) |
| 2023-12-12 | 2023-12-08 | 2023-12-08 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | dsp | 170.0 | 3.93 | 0.01 | 239.29 | Direct | Common Stock | BIOGEN INC. | code F | 4154.7483 | 144.9 (BIIB) |
| 2023-12-12 | 2023-12-08 | 2023-12-08 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | acq | 351.0 | 8.12 | 0.02 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 4324.7483 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-08 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | acq | 788.0 | 15.94 | 0.05 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 4942.7483 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-08 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | dsp | 253.0 | 5.12 | 0.02 | 240.3 | Direct | Common Stock | BIOGEN INC. | code F | 4689.7483 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | dsp | 245.0 | 4.44 | 0.02 | 240.98 | Direct | Common Stock | BIOGEN INC. | code F | 5277.7483 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | acq | 833.0 | 15.08 | 0.06 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 5522.7483 | 144.9 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | dsp | 396.0 | 5.98 | 0.03 | 219.08 | Direct | Common Stock | BIOGEN INC. | code F | 6226.7483
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | acq | 1345.0 | 21.17 | 0.09 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 6353.7483
|
145.36 (BIIB) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-05 | 2023-06-30 | 2023-06-30 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | dsp | 252.0 | 100.0 | 0.02 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 0.0 | 144.74 (BIIB) |
| 2023-12-12 | 2023-12-08 | 2023-12-08 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | dsp | 351.0 | 50.0 | 0.02 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 351.0 | 144.9 (BIIB) |
| 2023-12-26 | 2023-12-21 | 2023-12-21 | 4 | Kramer Robin | DIRECTOR | acq | 10461.0 | 100.0 | 2.89 | 2.39 | Direct | Stock Options (Right To Buy) | ARMATA PHARMACEUTICALS, INC. | code A | 10461.0 | 36.15 (ARMP) |
| 2024-01-31 | 2024-01-29 | 2024-01-29 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | acq | 914.0 | 100.0 | 0.06 | 0.0 | Direct | Performance Stock Unit | BIOGEN INC. | code A | 914.0 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-07 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | acq | 2110.0 | 100.0 | 0.15 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code A | 2110.0 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-08 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | dsp | 788.0 | 33.32 | 0.05 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 1577.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | dsp | 833.0 | 49.97 | 0.06 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 834.0 | 144.9 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | dsp | 968.0 | 100.0 | 0.07 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code J M | 0.0
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Kramer Robin | CHIEF ACCOUNTING OFFICER | dsp | 914.0 | 100.0 | 0.06 | 0.0 | Direct | Performance Stock Unit | BIOGEN INC. | code M | 0.0 | 145.36 (BIIB) |
| 2024-03-18 | 2024-03-14 | 2024-03-14 | 4 | Kramer Robin | DIRECTOR | acq | 94009.0 | 100.0 | 26.01 | 3.38 | Direct | Stock Options (Right To Buy) | ARMATA PHARMACEUTICALS, INC. | code A | 94009.0
|
36.15 (ARMP) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)